Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gemini Investors is a private equity investment firm focused on the smaller end of the U.S. middle market rather than a biotech, pharma, or healthcare operating company. Founded in 1993 and based in Wellesley, Massachusetts, the firm provides equity and subordinated debt capital for growth capital, acquisitions, recapitalizations, and buyouts. Gemini invests across multiple sectors, including healthcare, business services, technology, education, manufacturing, and consumer-related industries. In healthcare, it has backed services and healthcare-adjacent companies such as clinical research and rehabilitation businesses, but it does not appear to develop therapeutic products itself. For a biotech analyst, Gemini is best characterized as a sector-agnostic lower middle-market financial sponsor with selective healthcare exposure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gemini Investors.